Clinical Trials Browser

Interventional × Breast Cancer Metastatic × Docetaxel × Clear all

NCT05301010 2023-02-27

Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients

Phase 3 Completed

Breast Cancer Metastatic

NCT01876251 2019-03-15

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Phase 1 Terminated

30 enrolled 29 charts

Breast Cancer Metastatic